Evaluation of High-dose versus Standard-dose of Dexamethasone on Mortality among the Mechanically Ventilated COVID-19 Patients
CONCLUSION: There was no association between HD DEX and mortality among ventilated COVID-19 patients compared to SD DEX. Moreover, HD DEX is associated with detrimental effects such as prolonged ICU LOS and higher average daily BG. This study supports the use of SD DEX in ventilated COVID-19 patients.PMID:37592771 | DOI:10.2174/1574886318666230817102043 (Source: Current Drug Safety)
Source: Current Drug Safety - August 18, 2023 Category: Drugs & Pharmacology Authors: Pramodini B Kale-Pradhan Regina Pacitto Christopher A Giuliano Leonard B Johnson Source Type: research
Chemotherapy-Induced Peripheral Neuropathy Impacts Quality Of Life And Activities Of Daily Living Of Brazilian Multiple Myeloma Patients
CONCLUSION: MM patients showed a high frequency of CIPN, which affected ADL and impaired HRQoL. Early and accurate detection of CIPN and dose management in patients with thalidomide and bortezomib-based regimens should be performed to provide better treatment outcomes and avoid permanent disabilities.PMID:37592770 | DOI:10.2174/1574886318666230817162424 (Source: Current Drug Safety)
Source: Current Drug Safety - August 18, 2023 Category: Drugs & Pharmacology Authors: Paula Lana de Miranda Drummond Roberta M árcia Marques Dos Santos L ívia Pena Silveira J éssica Soares Malta Adriano Max Moreira Reis Naiane Lima Costa Roberta Oliveira de Paula E Silva Evandro Maranh ão Fagundes Cristiane Aparecida Menezes de P ádua Source Type: research
Evaluation of High-dose versus Standard-dose of Dexamethasone on Mortality among the Mechanically Ventilated COVID-19 Patients
CONCLUSION: There was no association between HD DEX and mortality among ventilated COVID-19 patients compared to SD DEX. Moreover, HD DEX is associated with detrimental effects such as prolonged ICU LOS and higher average daily BG. This study supports the use of SD DEX in ventilated COVID-19 patients.PMID:37592771 | DOI:10.2174/1574886318666230817102043 (Source: Current Drug Safety)
Source: Current Drug Safety - August 18, 2023 Category: Drugs & Pharmacology Authors: Pramodini B Kale-Pradhan Regina Pacitto Christopher A Giuliano Leonard B Johnson Source Type: research
Chemotherapy-Induced Peripheral Neuropathy Impacts Quality Of Life And Activities Of Daily Living Of Brazilian Multiple Myeloma Patients
CONCLUSION: MM patients showed a high frequency of CIPN, which affected ADL and impaired HRQoL. Early and accurate detection of CIPN and dose management in patients with thalidomide and bortezomib-based regimens should be performed to provide better treatment outcomes and avoid permanent disabilities.PMID:37592770 | DOI:10.2174/1574886318666230817162424 (Source: Current Drug Safety)
Source: Current Drug Safety - August 18, 2023 Category: Drugs & Pharmacology Authors: Paula Lana de Miranda Drummond Roberta M árcia Marques Dos Santos L ívia Pena Silveira J éssica Soares Malta Adriano Max Moreira Reis Naiane Lima Costa Roberta Oliveira de Paula E Silva Evandro Maranh ão Fagundes Cristiane Aparecida Menezes de P ádua Source Type: research
Evaluation of High-dose versus Standard-dose of Dexamethasone on Mortality among the Mechanically Ventilated COVID-19 Patients
CONCLUSION: There was no association between HD DEX and mortality among ventilated COVID-19 patients compared to SD DEX. Moreover, HD DEX is associated with detrimental effects such as prolonged ICU LOS and higher average daily BG. This study supports the use of SD DEX in ventilated COVID-19 patients.PMID:37592771 | DOI:10.2174/1574886318666230817102043 (Source: Current Drug Safety)
Source: Current Drug Safety - August 18, 2023 Category: Drugs & Pharmacology Authors: Pramodini B Kale-Pradhan Regina Pacitto Christopher A Giuliano Leonard B Johnson Source Type: research
Incidence and Severity of Adverse Drug Reactions in Medical Intensive Care Unit
CONCLUSION: In this study, a similar incidence rate of ADRA and ADRH was observed. The average cost for treating ADRA was higher than that for treating ADRH. As a result, identifying and preventing these reactions is critical, as they cause the patient greater suffering.PMID:37587829 | DOI:10.2174/1574886318666230816090606 (Source: Current Drug Safety)
Source: Current Drug Safety - August 17, 2023 Category: Drugs & Pharmacology Authors: Sana Shaikh Asawari Raut Prajkta Jambhale Shivkumar Iyer Jignesh Shah Source Type: research
Amphotericin-b-induced chronic kidney disease in a post-covid-19 patient with widespread rhinocerebral mucormycosis and pneumonia: A CASE REPORT
CONCLUSION: While COVID-19 has presented challenges and uncertainties, it has also provided valuable insights into the interactions between infectious agents and the human body. Continued research and vigilance are necessary to mitigate the impact of co-infections and improve outcomes for patients.PMID:37537934 | DOI:10.2174/1574886318666230804101539 (Source: Current Drug Safety)
Source: Current Drug Safety - August 4, 2023 Category: Drugs & Pharmacology Authors: Nishant Johri Ambika Choudhary Ujjawal Rawat Maheshwari Vengat Source Type: research
Amphotericin-b-induced chronic kidney disease in a post-covid-19 patient with widespread rhinocerebral mucormycosis and pneumonia: A CASE REPORT
CONCLUSION: While COVID-19 has presented challenges and uncertainties, it has also provided valuable insights into the interactions between infectious agents and the human body. Continued research and vigilance are necessary to mitigate the impact of co-infections and improve outcomes for patients.PMID:37537934 | DOI:10.2174/1574886318666230804101539 (Source: Current Drug Safety)
Source: Current Drug Safety - August 4, 2023 Category: Drugs & Pharmacology Authors: Nishant Johri Ambika Choudhary Ujjawal Rawat Maheshwari Vengat Source Type: research
Amphotericin-b-induced chronic kidney disease in a post-covid-19 patient with widespread rhinocerebral mucormycosis and pneumonia: A CASE REPORT
CONCLUSION: While COVID-19 has presented challenges and uncertainties, it has also provided valuable insights into the interactions between infectious agents and the human body. Continued research and vigilance are necessary to mitigate the impact of co-infections and improve outcomes for patients.PMID:37537934 | DOI:10.2174/1574886318666230804101539 (Source: Current Drug Safety)
Source: Current Drug Safety - August 4, 2023 Category: Drugs & Pharmacology Authors: Nishant Johri Ambika Choudhary Ujjawal Rawat Maheshwari Vengat Source Type: research
Amphotericin-b-induced chronic kidney disease in a post-covid-19 patient with widespread rhinocerebral mucormycosis and pneumonia: A CASE REPORT
CONCLUSION: While COVID-19 has presented challenges and uncertainties, it has also provided valuable insights into the interactions between infectious agents and the human body. Continued research and vigilance are necessary to mitigate the impact of co-infections and improve outcomes for patients.PMID:37537934 | DOI:10.2174/1574886318666230804101539 (Source: Current Drug Safety)
Source: Current Drug Safety - August 4, 2023 Category: Drugs & Pharmacology Authors: Nishant Johri Ambika Choudhary Ujjawal Rawat Maheshwari Vengat Source Type: research
Amphotericin-b-induced chronic kidney disease in a post-covid-19 patient with widespread rhinocerebral mucormycosis and pneumonia: A CASE REPORT
CONCLUSION: While COVID-19 has presented challenges and uncertainties, it has also provided valuable insights into the interactions between infectious agents and the human body. Continued research and vigilance are necessary to mitigate the impact of co-infections and improve outcomes for patients.PMID:37537934 | DOI:10.2174/1574886318666230804101539 (Source: Current Drug Safety)
Source: Current Drug Safety - August 4, 2023 Category: Drugs & Pharmacology Authors: Nishant Johri Ambika Choudhary Ujjawal Rawat Maheshwari Vengat Source Type: research
Amphotericin-b-induced chronic kidney disease in a post-covid-19 patient with widespread rhinocerebral mucormycosis and pneumonia: A CASE REPORT
CONCLUSION: While COVID-19 has presented challenges and uncertainties, it has also provided valuable insights into the interactions between infectious agents and the human body. Continued research and vigilance are necessary to mitigate the impact of co-infections and improve outcomes for patients.PMID:37537934 | DOI:10.2174/1574886318666230804101539 (Source: Current Drug Safety)
Source: Current Drug Safety - August 4, 2023 Category: Drugs & Pharmacology Authors: Nishant Johri Ambika Choudhary Ujjawal Rawat Maheshwari Vengat Source Type: research
Amphotericin-b-induced chronic kidney disease in a post-covid-19 patient with widespread rhinocerebral mucormycosis and pneumonia: A CASE REPORT
CONCLUSION: While COVID-19 has presented challenges and uncertainties, it has also provided valuable insights into the interactions between infectious agents and the human body. Continued research and vigilance are necessary to mitigate the impact of co-infections and improve outcomes for patients.PMID:37537934 | DOI:10.2174/1574886318666230804101539 (Source: Current Drug Safety)
Source: Current Drug Safety - August 4, 2023 Category: Drugs & Pharmacology Authors: Nishant Johri Ambika Choudhary Ujjawal Rawat Maheshwari Vengat Source Type: research
Amphotericin-b-induced chronic kidney disease in a post-covid-19 patient with widespread rhinocerebral mucormycosis and pneumonia: A CASE REPORT
CONCLUSION: While COVID-19 has presented challenges and uncertainties, it has also provided valuable insights into the interactions between infectious agents and the human body. Continued research and vigilance are necessary to mitigate the impact of co-infections and improve outcomes for patients.PMID:37537934 | DOI:10.2174/1574886318666230804101539 (Source: Current Drug Safety)
Source: Current Drug Safety - August 4, 2023 Category: Drugs & Pharmacology Authors: Nishant Johri Ambika Choudhary Ujjawal Rawat Maheshwari Vengat Source Type: research
Amphotericin-b-induced chronic kidney disease in a post-covid-19 patient with widespread rhinocerebral mucormycosis and pneumonia: A CASE REPORT
CONCLUSION: While COVID-19 has presented challenges and uncertainties, it has also provided valuable insights into the interactions between infectious agents and the human body. Continued research and vigilance are necessary to mitigate the impact of co-infections and improve outcomes for patients.PMID:37537934 | DOI:10.2174/1574886318666230804101539 (Source: Current Drug Safety)
Source: Current Drug Safety - August 4, 2023 Category: Drugs & Pharmacology Authors: Nishant Johri Ambika Choudhary Ujjawal Rawat Maheshwari Vengat Source Type: research
